Paul A Baker
Examiner (ID: 6715)
Most Active Art Unit | 2188 |
Art Unit(s) | 2188, 2187 |
Total Applications | 122 |
Issued Applications | 115 |
Pending Applications | 3 |
Abandoned Applications | 4 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16297687
[patent_doc_number] => 20200283410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => Enantioselective Process For The Manufacture Of Lactam Carboxylate Derivatives
[patent_app_type] => utility
[patent_app_number] => 16/874165
[patent_app_country] => US
[patent_app_date] => 2020-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3035
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16874165
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/874165 | Enantioselective process for the manufacture of lactam carboxylate derivatives | May 13, 2020 | Issued |
Array
(
[id] => 16297686
[patent_doc_number] => 20200283409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => Pyrazole Derivatives
[patent_app_type] => utility
[patent_app_number] => 16/874136
[patent_app_country] => US
[patent_app_date] => 2020-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16874136
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/874136 | Pyrazole derivatives | May 13, 2020 | Issued |
Array
(
[id] => 16297686
[patent_doc_number] => 20200283409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => Pyrazole Derivatives
[patent_app_type] => utility
[patent_app_number] => 16/874136
[patent_app_country] => US
[patent_app_date] => 2020-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16874136
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/874136 | Pyrazole derivatives | May 13, 2020 | Issued |
Array
(
[id] => 16297686
[patent_doc_number] => 20200283409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => Pyrazole Derivatives
[patent_app_type] => utility
[patent_app_number] => 16/874136
[patent_app_country] => US
[patent_app_date] => 2020-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16874136
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/874136 | Pyrazole derivatives | May 13, 2020 | Issued |
Array
(
[id] => 16297686
[patent_doc_number] => 20200283409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => Pyrazole Derivatives
[patent_app_type] => utility
[patent_app_number] => 16/874136
[patent_app_country] => US
[patent_app_date] => 2020-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16874136
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/874136 | Pyrazole derivatives | May 13, 2020 | Issued |
Array
(
[id] => 16815702
[patent_doc_number] => 11000500
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-11
[patent_title] => Method of treating conditions related to the PGI2 receptor
[patent_app_type] => utility
[patent_app_number] => 16/870777
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27372
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16870777
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/870777 | Method of treating conditions related to the PGI2 receptor | May 7, 2020 | Issued |
Array
(
[id] => 16642047
[patent_doc_number] => 10919882
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Compounds for use in synthesis of peptidomimetics
[patent_app_type] => utility
[patent_app_number] => 16/869794
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19515
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16869794
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/869794 | Compounds for use in synthesis of peptidomimetics | May 7, 2020 | Issued |
Array
(
[id] => 16336472
[patent_doc_number] => 10787416
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-09-29
[patent_title] => Crystals of intermediate for benzindene prostaglandins and methods for preparation thereof
[patent_app_type] => utility
[patent_app_number] => 16/868624
[patent_app_country] => US
[patent_app_date] => 2020-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 4839
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16868624
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/868624 | Crystals of intermediate for benzindene prostaglandins and methods for preparation thereof | May 6, 2020 | Issued |
Array
(
[id] => 16238208
[patent_doc_number] => 20200255442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => ANTI-CANCER COMPOUNDS TARGETING RAL GTPASES AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/863867
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20782
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 243
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16863867
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/863867 | Anti-cancer compounds targeting Ral GTPases and methods of using the same | Apr 29, 2020 | Issued |
Array
(
[id] => 16512818
[patent_doc_number] => 20200392076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => ANTIVIRAL AGENTS FOR DRUG-RESISTANT INFLUENZA A
[patent_app_type] => utility
[patent_app_number] => 16/859121
[patent_app_country] => US
[patent_app_date] => 2020-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5857
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16859121
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/859121 | Antiviral agents for drug-resistant influenza A | Apr 26, 2020 | Issued |
Array
(
[id] => 17120534
[patent_doc_number] => 11131661
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-28
[patent_title] => Compounds inhibiting Nef-calnexin interaction
[patent_app_type] => utility
[patent_app_number] => 16/841444
[patent_app_country] => US
[patent_app_date] => 2020-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 20
[patent_no_of_words] => 13134
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16841444
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/841444 | Compounds inhibiting Nef-calnexin interaction | Apr 5, 2020 | Issued |
Array
(
[id] => 17649603
[patent_doc_number] => 11352317
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Rosin-based small molecular weight hydrogelator and its application
[patent_app_type] => utility
[patent_app_number] => 16/832034
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 6570
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16832034
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/832034 | Rosin-based small molecular weight hydrogelator and its application | Mar 26, 2020 | Issued |
Array
(
[id] => 18251874
[patent_doc_number] => 20230078913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => ANDROGEN RECEPTOR MODULATORS AND METHODS FOR USE AS PROTEOLYSIS TARGETING CHIMERA LIGANDS
[patent_app_type] => utility
[patent_app_number] => 17/599341
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 78288
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -51
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17599341
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/599341 | ANDROGEN RECEPTOR MODULATORS AND METHODS FOR USE AS PROTEOLYSIS TARGETING CHIMERA LIGANDS | Mar 26, 2020 | Pending |
Array
(
[id] => 17687679
[patent_doc_number] => 20220194971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/599816
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6712
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17599816
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/599816 | SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS | Mar 26, 2020 | Abandoned |
Array
(
[id] => 17227207
[patent_doc_number] => 20210353763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => SITE-SPECIFIC COVALENT CHEMICAL LIGATION TO MONOCLONAL AND POLYCLONAL IMMUNOGLOBULIN
[patent_app_type] => utility
[patent_app_number] => 16/820096
[patent_app_country] => US
[patent_app_date] => 2020-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16820096
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/820096 | SITE-SPECIFIC COVALENT CHEMICAL LIGATION TO MONOCLONAL AND POLYCLONAL IMMUNOGLOBULIN | Mar 15, 2020 | Abandoned |
Array
(
[id] => 16090205
[patent_doc_number] => 20200199089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => TETRAHYDRONAPHTHO[1,2-B]FURAN-2(3H)-ONE DERIVATIVES AND PREPARATION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/741844
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 309
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16741844
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/741844 | Tetrahydronaphtho[1,2-b]furan-2(3H)-one derivatives and preparation and uses thereof | Mar 12, 2020 | Issued |
Array
(
[id] => 18117476
[patent_doc_number] => 11548857
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-10
[patent_title] => Biodegradable compound, lipid particle, composition comprising lipid particle, and kit
[patent_app_type] => utility
[patent_app_number] => 16/812625
[patent_app_country] => US
[patent_app_date] => 2020-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 14375
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16812625
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/812625 | Biodegradable compound, lipid particle, composition comprising lipid particle, and kit | Mar 8, 2020 | Issued |
Array
(
[id] => 16108267
[patent_doc_number] => 20200206156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => Compositions and Methods for Treatment or Prevention of Oral Mucositis
[patent_app_type] => utility
[patent_app_number] => 16/813650
[patent_app_country] => US
[patent_app_date] => 2020-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5098
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16813650
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/813650 | Compositions and methods for treatment or prevention of oral mucositis | Mar 8, 2020 | Issued |
Array
(
[id] => 16533286
[patent_doc_number] => 10875869
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-12-29
[patent_title] => Diazacyclobutene derivatives and methods of synthesis thereof
[patent_app_type] => utility
[patent_app_number] => 16/811264
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6699
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16811264
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/811264 | Diazacyclobutene derivatives and methods of synthesis thereof | Mar 5, 2020 | Issued |
Array
(
[id] => 16111483
[patent_doc_number] => 20200207764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => DIHYDROBENZIMIDAZOLONES FOR MEDICAL TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/809325
[patent_app_country] => US
[patent_app_date] => 2020-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16809325
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/809325 | Dihydrobenzimidazolones for medical treatment | Mar 3, 2020 | Issued |